miR-148a regulates expression of the transferrin receptor 1 in hepatocellular carcinoma

被引:0
|
作者
Kamesh R. Babu
Martina U. Muckenthaler
机构
[1] University of Heidelberg,Department of Pediatric Hematology, Oncology, and Immunology
[2] University of Heidelberg,Molecular Medicine Partnership Unit
来源
关键词
D O I
暂无
中图分类号
学科分类号
摘要
Transferrin receptor 1 (TFR1) is a transmembrane glycoprotein that allows for transferrin-bound iron uptake in mammalian cells. It is overexpressed in various cancers to satisfy the high iron demand of fast proliferating cells. Here we show that in hepatocellular carcinoma (HCC) TFR1 expression is regulated by miR-148a. Within the TFR1 3′UTR we identified and experimentally validated two evolutionarily conserved miRNA response elements (MREs) for miR-148/152 family members, including miR-148a. Interestingly, analyses of RNA sequencing data from patients with liver hepatocellular carcinoma (LIHC) revealed a significant inverse correlation of TFR1 mRNA levels and miR-148a. In addition, TFR1 mRNA levels were significantly increased in the tumor compared to matched normal healthy tissue, while miR-148a levels are decreased. Functional analysis demonstrated post-transcriptional regulation of TFR1 by miR-148a in HCC cells as well as decreased HCC cell proliferation upon either miR-148a overexpression or TFR1 knockdown. We hypothesize that decreased expression of miR-148a in HCC may elevate transferrin-bound iron uptake, increasing cellular iron levels and cell proliferation.
引用
下载
收藏
相关论文
共 50 条
  • [21] HLA-G expression and miR-148a, miR-152 in colorectal adenocarcinoma
    Emirzeoglu, Levent
    Karagoz, Bulent
    Berber, Ufuk
    Tanoglu, Alpaslan
    Celik, Serkan
    Ozgun, Alpaslan
    Bilgi, Oguz
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [22] MiR-148b-3p Regulates the Expression of DTYMK to Drive Hepatocellular Carcinoma Cell Proliferation and Metastasis
    He, Guifang
    Qiu, Jing
    Liu, Changchang
    Tian, Ben
    Cai, Duo
    Liu, Shihai
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [23] MiR-148a modulates HLA-G expression and influences tumor apoptosis in esophageal squamous cell carcinoma
    Chen, Quan
    Luo, Guanghua
    Zhang, Xiaoying
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2017, 14 (05) : 4448 - 4452
  • [24] Role of miR-148a in cutaneous squamous cell carcinoma by repression of MAPK pathway
    Luo, Quan
    Li, Wei
    Zhao, Tian
    Tian, Xin
    Liu, Yumei
    Zhang, Xibao
    ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 2015, 583 : 47 - 54
  • [25] Altered Expression of MiR-148a and MiR-152 in Gastrointestinal Cancers and Its Clinical Significance
    Chen, Yue
    Song, Yongxi
    Wang, Zhenning
    Yue, Zhenyu
    Xu, Huimian
    Xing, Chengzhong
    Liu, Zhuangkai
    JOURNAL OF GASTROINTESTINAL SURGERY, 2010, 14 (07) : 1170 - 1179
  • [26] Altered expression of miR-152 and miR-148a in ovarian cancer is related to cell proliferation
    Zhou, Xin
    Zhao, Fang
    Wang, Zhen-Ning
    Song, Yong-Xi
    Chang, Hua
    Chiang, Yeunpo
    Xu, Hui-Mian
    ONCOLOGY REPORTS, 2012, 27 (02) : 447 - 454
  • [27] Functional role of miR-148a in oropharyngeal cancer: influence on pregnane X receptor and P-glycoprotein expression
    Reuter, Tasmin
    Herold-Mende, Christel
    Dyckhoff, Gerhard
    Rigalli, Juan Pablo
    Weiss, Johanna
    JOURNAL OF RECEPTORS AND SIGNAL TRANSDUCTION, 2019, 39 (5-6) : 451 - 459
  • [28] Expression profile of miR-148a and miR-155 associated with apoptosis mechanism in pancreatic cancer
    Novais, Paulo C.
    Moscatel, Matheus B.
    Rosa, Marcella S.
    Tirapelli, Daniela
    Cirino, Mucio L.
    Kemp, Rafael
    Santos, Jose S.
    FASEB JOURNAL, 2022, 36
  • [29] Altered Expression of MiR-148a and MiR-152 in Gastrointestinal Cancers and Its Clinical Significance
    Yue Chen
    Yongxi Song
    Zhenning Wang
    Zhenyu Yue
    Huimian Xu
    Chengzhong Xing
    Zhuangkai Liu
    Journal of Gastrointestinal Surgery, 2010, 14 : 1170 - 1179
  • [30] MiR-148a induces apoptosis by upregulating BIM expression in gastric cancer cells
    Zhang, Maoshen
    Wang, Chenghong
    Mu, Lihua
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2017, 10 (02): : 2791 - 2799